Pulmonary manifestations of amyloidosis

被引：4

作者：

Khan, Nauman A. ^{[1
]}

Bhandari, Bharat S. ^{[1
]}

Jyothula, Soma ^{[2
]}

Ocazionez, Daniel ^{[3
]}

Buryanek, Jamie ^{[4
]}

Jani, Pushan P. ^{[1
]}

机构：

[1] Univ Texas Houston, McGovern Sch Med, Dept Pulm Crit Care & Sleep Med, Houston, TX 77204 USA

[2] Methodist Hosp, South Texas Med Ctr, Dept Pulm Med & Lung Transplant, San Antonio, TX USA

[3] Univ Texas Houston, McGovern Med Sch Houston, Dept Diagnost & Intervent Imaging, Houston, TX USA

[4] Univ Texas Houston, McGovern Med Sch, Dept Pathol & Lab Med, Houston, TX USA

来源：

RESPIRATORY MEDICINE | 2023年 / 219卷

关键词：

Pulmonary amyloidosis; Endobronchial amyloidosis; Pleural amyloidosis; Cystic amyloid; PRIMARY SYSTEMIC AMYLOIDOSIS; LOWER RESPIRATORY-TRACT; TRACHEOBRONCHIAL AMYLOIDOSIS; PLEURAL EFFUSIONS; CLASSIFICATION; HYPERTENSION; ASSOCIATION; EXPERIENCE; DISEASE; SERIES;

D O I：

10.1016/j.rmed.2023.107426

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Amyloidosis is caused by abnormal protein deposition in various tissues, including the lungs. Pulmonary manifestations of amyloidosis may be categorized by areas of involvement, such as parenchymal, large airway and pleural involvement. We describe four distinct manifestations of amyloidosis involving the lung and review their clinical, radiological and pathological features and summarize the evidence for treatment in each of these presentations. We describe alveolar-septal amyloidosis, cystic amyloid lung disease, endobronchial amyloidosis and pleural amyloidosis.

引用

页数：8

共 64 条

[1] Authier F J, 1999, J Clin Neuromuscul Dis, V1, P82, DOI 10.1097/00131402-199912000-00006
[2] Amyloid in the Lung
Baqir, Misbah
Roden, Anja C.
Moua, Teng
[J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (02) : 299 - 310
[3] Amyloid-associated cystic lung disease in primary Sjogren's syndrome
Baqir, Misbah
Kluka, Elizabeth M.
Aubry, Marie-Christine
Hartman, Thomas E.
Yi, Eunhee S.
Bauer, Philippe R.
Ryu, Jay H.
[J]. RESPIRATORY MEDICINE, 2013, 107 (04) : 616 - 621
[4] Local vs. systemic pulmonary amyloidosis-impact on diagnostics and clinical management
Baumgart, Julius-Valentin
Stuhlmann-Laeisz, Christiane
Hegenbart, Ute
Nattenmueller, Johanna
Schoenland, Stefan
Krueger, Sandra
Behrens, Hans-Michael
Roecken, Christoph
[J]. VIRCHOWS ARCHIV, 2018, 473 (05) : 627 - 637
[5] Tracheobronchial Tumors: Radiologic-Pathologic Correlation of Tumors and Mimics
Bedayat, Arash
Yang, Eric
Ghandili, Saeed
Galera, Pallavi
Chalian, Hamid
Ansari-Gilani, Kianoush
Guo, Heiwei Henry
[J]. CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2020, 49 (04) : 275 - 284
[6] Pleural effusions in systemic amyloidosis
Berk, JL
[J]. CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (04) : 324 - 328
[7] Persistent pleural effusions in primary systemic amyloidosis - Etiology and prognosis
Berk, JL
Keane, J
Seldin, DC
Sanchorawala, V
Koyama, J
Dember, LM
Falk, RH
[J]. CHEST, 2003, 124 (03) : 969 - 977
[8] Pulmonary and tracheobronchial amyloidosis
Berk, JL
O'Regan, A
Skinner, M
[J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 23 (02) : 155 - 165
[9] AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies
Bianchi, Giada
Zhang, Yifei
Comenzo, Raymond L.
[J]. JACC: CARDIOONCOLOGY, 2021, 3 (04): : 467 - 487
[10] Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis
Binder, Christina
Duca, Franz
Binder, Thomas
Rettl, Rene
Dachs, Theresa Marie
Seirer, Benjamin
Camuz Ligios, Luciana
Dusik, Fabian
Capelle, Christophe
Qin, Hong
Agis, Hermine
Kain, Renate
Hengstenberg, Christian
Badr Eslam, Roza
Bonderman, Diana
[J]. CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (04) : 532 - 543

← 1 2 3 4 5 6 7 →